We have developed two systems for performing Cre-mediated recombination of
target genes in the rapidly self-renewing mouse small intestinal and coloni
c epithelium, When expression of Cre recombinase is placed directly under t
he control of transcriptional regulatory elements from a fatty acid-binding
protein gene (Fabp), deletion of loxP flanked (floxed) DNA sequences is in
itiated as early as embryonic day 13.5, well before completion of intestina
l morphogenesis. By embryonic day 16.5, Fabp-Cre also directs recombination
in all cell layers of the transitional epithelium that lines the renal cal
yces and pelvis, meters, and bladder, Fabp-Cre expression and recombination
are maintained in both epithelia throughout adulthood. The second system a
llows recombination to be induced only in the gut and at any period during
adulthood. This system uses Fabp regulatory elements to direct expression o
f a reverse tetracycline-regulated transactivator (rtTA), Another transgene
encodes Cre under the control of tet operator sequences and a minimal prom
oter from human cytomegalovirus (tetO-P-hCMV-Cre). In the absence of a doxy
cycline inducer, no basal recombination is detectable in the gut of adult t
ri-transgenic mice containing Fabp-rtTA, tetO-P-hCMV-Cre, plus a floxed rep
orter gene. After 4 days of oral administration of doxycycline, recombinati
on of the reporter is apparent in the small intestinal, cecal, and colonic
epithelium, After doxycycline is withdrawn, the recombined locus persists f
or at least 60 days, indicating that recombination has occurred in epitheli
al cell progenitors that have long residency times in the proliferative uni
ts of the intestine (crypts of Lieberkuhn), This inducible system should ha
ve a number of applications for examining gene function at selected times i
n postnatal life, under selected physiologic or pathophysiologic conditions
.